PharmaBlock Sciences (Nanjing), Inc.

PharmaBlock is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in the design, synthesis, and supply of innovative pharmaceutical molecular building blocks. Founded in 2006, the company has established itself as a pioneer in the field, supporting drug discovery and development for over 80% of the world's top 20 pharmaceutical companies and hundreds of biotech firms. The company's core business revolves around its rationally designed collection of over 200,000 building blocks, which are used to explore structure-activity relationships (SAR) and accelerate the drug R&D process. PharmaBlock also provides comprehensive CDMO services, including process R&D and GMP manufacturing of intermediates and Active Pharmaceutical Ingredients (APIs). They are particularly recognized for their expertise in green chemistry and low-carbon technologies, such as continuous flow chemistry, biocatalysis, and micropacked bed hydrogenation.